To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05659563
Title Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67>=10% (EMPRESS)
Acronym EMPRESS
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP

Facility Status City State Zip Country Details
Hopital Europeen Georges Pompidou Paris France Details
Hôpital Tenon AP-HP Paris France Details
Institut Català d' Oncologia Badalona Badalona Barcelona Spain Details
Hospital Universitari Sant Joan de Reus Reus Tarragona Spain Details
Hospital General Universitario Dr. Balmis Alicante 03010 Spain Details
Hospital Clínic i Provincial de Barcelona Barcelona Spain Details
Hospital Universitari Dexeus Barcelona Spain Details
Hospital Universitario Reina Sofía Cordoba Spain Details
Hospital Universitario Clínico San Cecilio de Granada Granada 18016 Spain Details
Hospital Universitario de León León Spain Details
Hospital Beata Maria Ana Madrid Spain Details
Hospital Universitario La Paz Madrid Spain Details
Hospital Universitario Ramón y Cajal Madrid Spain Details
Hospital Clínico Universitario Virgen de la Arrixaca Murcia Spain Details
Hospital Universitario Virgen del Rocío Sevilla 41013 Spain Details
Hospital Arnau de Vilanova de Valencia Valencia 46015 Spain Details
Hospital Clinico Universitario de Valencia Valencia Spain Details
Instituto Valenciano de Oncología Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field